Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells.
about
Erythropoietin in ophthalmology: A literature reviewPigment epithelium-derived factor protects retinal ganglion cells.TSP-1 secreted by bone marrow stromal cells contributes to retinal ganglion cell neurite outgrowth and survival.Oxidative stress: Biomarkers and novel therapeutic pathways.Serum erythropoietin levels in patients with central serous chorioretinopathy.New strategies for Alzheimer's disease and cognitive impairment.The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain.Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-α-induced damage.Serotonin levels in aqueous humor of patients with primary open-angle glaucoma.Erythropoietin upregulates growth associated protein-43 expression and promotes retinal ganglion cell axonal regeneration in vivo after optic nerve crushSystemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA/2J glaucomatous miceErythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrityMicroglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB.Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.Erythropoietin: elucidating new cellular targets that broaden therapeutic strategiesErythropoietin and oxidative stress.Erythropoietin modulation of astrocyte water permeability as a component of neuroprotectionThe vitamin nicotinamide: translating nutrition into clinical care.Revisiting the role of erythropoietin for treatment of ocular disorders.IGF-1 protects retinal ganglion cells from hypoxia-induced apoptosis by activating the Erk-1/2 and Akt pathways.Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype.The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats.Brain-derived neurotrophic factor released from engineered mesenchymal stem cells attenuates glutamate- and hydrogen peroxide-mediated death of staurosporine-differentiated RGC-5 cells.Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells.EPO-dependent activation of PI3K/Akt/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease.Erythropoietin (EPO) protects against high glucose-induced apoptosis in retinal ganglional cells.High cerebrospinal fluid antioxidants and interleukin 8 are protective of hypoxic brain damage in newborns.Safety threshold of intravitreal clonidine in rabbit's eyes.Neuroprotective Effect of Lutein on NMDA-Induced Retinal Ganglion Cell Injury in Rat Retina.Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury.Cerebral adaptations to chronic anemia in a model of erythropoietin-deficient mice exposed to hypoxia.
P2860
Q26744850-6DA474D9-2370-47B8-B969-5CF8B48E40BEQ33270756-EBC6BDDE-2579-4C8E-BFAA-79B94562E84DQ33346315-FED528C0-4BEC-4D6B-A990-577ECC60C924Q33682262-7408B992-0C35-488D-A5C5-2E8F0141CEA6Q33702107-1935C735-3547-458E-8D86-D693FD655E1EQ33717008-75962FBF-B795-4F0D-A9EF-E2A7D0076142Q34100527-92E860A2-252A-4837-B1CC-DCFD7E7BDD96Q34117531-7F66F05B-3ECD-4129-AEDB-A7918056FB23Q34576332-68839B71-BE3D-4B2A-9208-FCE19E9A2485Q34601286-58427C4F-8353-4CD1-85D9-342110B74BA1Q35157715-E60C7CF5-76C1-43AE-891D-2C3897B0A2CEQ35496394-FA3BE9E4-BBCA-4CC6-A298-2CC837A74969Q35950357-2D67FAAB-4538-45A5-965E-00892798EE6CQ36002858-D929251B-674B-44D3-ABCD-8459381E1B94Q36727444-4B6596FC-6366-460D-85B6-EA121D335D86Q36740470-D41EA4DB-BCFA-418D-86FF-73F923094272Q36944477-7C3913A6-81B7-4BC6-B701-A0975FEAD497Q37068999-7E97A65C-40E8-4A25-AA7D-78E0AEBF47C1Q37374047-939E1E31-FBB0-4BCF-9AA3-5E7760BA1EBCQ38855251-F463C120-E64A-453B-B777-CDEA9D83B36EQ39613662-BB3680AD-C62C-4E2B-8EDE-772F960DBE02Q40076490-34AF8DCD-6BA2-4552-A2C5-38DA5B72EA27Q41239132-606C8200-8494-4A13-80D3-3D8ED6D8F467Q41811778-5F65558F-F6D4-4FED-9F42-5B6498112486Q41887005-D1BFD21C-6946-45F1-8A23-43BFA9FF25A2Q43688071-6B6FD3D7-7795-4642-88E5-EA50483E2E54Q46829128-0AA0E114-99F5-45BF-A240-30E08EF74007Q48301966-115B4AE3-42C3-45CA-888E-8AAFA838C255Q49381318-8E667DFA-BCC4-4FED-9B13-F305CBAED545Q53450537-4A7EAA49-4A2A-40AD-9428-DCCD2C2006B0Q53646442-809D47A6-F95F-49CA-AAAE-7EE6C93CB570Q54501438-0E91533B-905E-4138-AD98-64A6E3552DE4
P2860
Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Neuroprotective effects of ery ...... ltured retinal ganglion cells.
@en
Neuroprotective effects of ery ...... ltured retinal ganglion cells.
@nl
type
label
Neuroprotective effects of ery ...... ltured retinal ganglion cells.
@en
Neuroprotective effects of ery ...... ltured retinal ganglion cells.
@nl
prefLabel
Neuroprotective effects of ery ...... ltured retinal ganglion cells.
@en
Neuroprotective effects of ery ...... ltured retinal ganglion cells.
@nl
P2093
P1433
P1476
Neuroprotective effects of ery ...... ltured retinal ganglion cells.
@en
P2093
Atsushi Minamoto
Hidetoshi Yamashita
Hiromu K Mishima
Kazuhiko Murata
Kenji Kashiwagi
Makiko Yamasaki
Toshiya Inaba
P356
10.1016/J.BRAINRES.2005.05.037
P407
P577
2005-07-01T00:00:00Z